News

Researchers discovered that recall germinal centers, activated upon re-exposure to pathogens, draw on naive B cells to create new antibodies while experienced B cells respond immediately.

A more targeted therapy for multiple sclerosis that uses special immune cells from the patients has shown early promise.

An array of nanopillars that can breach the nucleus of cells without damaging the membrane could open new possibilities in gene therapy.

Researchers aim to improve commercial glucagon stability and prevent hypoglycemia by using micelles: nanoscale, soap-like bubbles that can be customized to assemble or disassemble in different environments and are used for drug delivery.

Individuals fully vaccinated against COVID-19 have a significantly lower risk of developing more severe cardiovascular conditions linked to COVID-19 infection, yet some cardiovascular effects have been seen after individual doses of the vaccine.

A study reveals that natural immunity gained from previous influenza infections enhances immune responses to subsequent vaccinations. This finding suggests that individuals who contract the flu may benefit in their battle against future strains.

Researchers at the University of Geneva developed CAR T cells targeting the glioblastoma marker PTPRZ1, showing efficacy against tumors. These cells not only attack marked tumor cells but also eliminate others through a bystander effect.

Vaccination coverage for COVID-19 is high in both people with and without mental illness. However, individuals with unmedicated mental illness have lower vaccination levels.

A single infusion of a new gene therapy can reduce the number of bleeding episodes by an average of 71%, according to a new study.

A review of sustained mammal-to-mammal bird flu transmission in diverse species, shows global control strategies are not working.